Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 7:21 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 553–576 of 1,485 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Scheduling Clear all

Conditions: Advanced Gastrointestinal Stromal Tumor (GIST)
Interventions: BGJ398, Imatinib Mesylate; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 7
States / cities: Boston, Massachusetts • Basking Ridge, New Jersey • Commack, New York + 4 more

Conditions: Tobacco Use Disorder, Tobacco Use Cessation, Cannabis Use, Cannabis Use Disorder, Marijuana Use
Interventions: Varenicline, Counseling, Psychosocial modules; Drug · Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Airway Morbidity, Intubation Complication, Tracheal Intubation Morbidity, Anesthesia Intubation Complication, Failed or Difficult Intubation, Sequela
Interventions: ZU-bend stylet, GlideScope, GlideRite stylet, Macintosh blade, Regular Double-lumen endobronchial tube (DLT) Stylet; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Patient Readmission, Pulmonary Disease, Chronic Obstructive, Heart Failure, Diabetes Mellitus Poor Control, Hypertension, Pneumonia
Interventions: Standard of Care, Enhanced Care; Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: La Plata, Maryland

Conditions: Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma, Neoadjuvant Pancreatic Cancer
Interventions: Paclitaxel Protein Bound (Abraxane); Drug
Lead sponsor: HonorHealth Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Hepatitis C
Interventions: Hepatitis C Treatment Alerts in CHORUS™, Standard of Care; Other
Lead sponsor: Epividian; Industry
Eligibility: 18 Years and older
Enrollment: 1,063 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer
Interventions: Nab-Paclitaxel, Gemcitabine, Indoximod; Drug
Lead sponsor: NewLink Genetics Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 11
States / cities: Palo Alto, California • Augusta, Georgia • Lexington, Kentucky + 8 more

Conditions: Leukemia
Interventions: 5-azacitidine, Allogeneic Hematopoietic Cell Transplantation (HCT); Drug · Procedure
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years to 68 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Heart Failure
Interventions: Medically Tailored Meals; Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 50 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Laceration of Skin, Anxiety, Discharge Time
Interventions: Intranasal Midazolam, Intranasal Dexmedetomidine, Intranasal Ketamine; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 1 Year to 5 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Colorectal Carcinoma
Interventions: Best Practice, Educational Intervention, Electronic Health Record Review, Interview, Supportive Care, Survey Administration; Other
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 45 Years to 75 Years
Enrollment: 682 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Opioid Use Disorder, Opioid Use Disorder, Severe, Opioid Use Disorder, Moderate
Interventions: Standard of Care Referral, Low Threshold Buprenorphine; Other · Behavioral
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 512 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 8
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Baton Rouge, Louisiana + 5 more

Conditions: Discogenic Pain, Low Back Pain, Chronic Pain
Interventions: Low back intradiscal injection of platelet rich plasma (PRP); Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Chronic Hepatitis C Virus
Interventions: SIMpill device; Device
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pressure Ulcer
Interventions: DabirAIR alternating pressure overlay; Device
Lead sponsor: Dabir Surfaces Inc; Industry
Eligibility: 18 Years and older
Enrollment: 392 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Prostate Cancer
Interventions: MRI scan; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 20 Years to 85 Years · Male only
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hepatitis C
Interventions: Hepatitis C Screening Alerts in CHORUS™, Standard of Care; Other
Lead sponsor: Epividian; Industry
Eligibility: 18 Years and older
Enrollment: 125,706 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Prostatic Neoplasms
Interventions: Radium-223 dichloride (Xofigo, BAY88-8223); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 391 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 12
States / cities: Scottsdale, Arizona • New Haven, Connecticut • Fort Myers, Florida + 9 more

Conditions: Perineal Injury, Pain Vulva, Perineum; Injury
Interventions: Perineal ice packs, medicated witch-hazel pads, and topical benzocaine spray; Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Substance Use Disorders
Interventions: Voucher Reinforcement, Standard Control; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Sickle Cell Disease, Pulmonary Disease, Renal Disease, Heart Disease
Interventions: Not listed
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 4 Years to 65 Years
Enrollment: 377 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Atlanta, Georgia • Baltimore, Maryland + 2 more

Conditions: Opioid Use Disorder, Neonatal Abstinence Syndrome, Child Development, Child Abuse, Child Neglect
Interventions: RESPECT-Plus; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: Up to 21 Days
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cocaine Use Disorder, Contingency Management
Interventions: prize contingency management on a traditional twice weekly schedule for cocaine abstinence, prize contingency management on a variable interval schedule for cocaine abstinence, standard care; Behavioral
Lead sponsor: UConn Health; Other
Eligibility: 18 Years and older
Enrollment: 274 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 4
States / cities: Bridgeport, Connecticut • Hartford, Connecticut • New Britain, Connecticut + 1 more

Conditions: Pediatric Solid Tumors, Rhabdomyosarcoma, Ewing Sarcoma, Osteosarcoma, Hodgkin Lymphoma, Bone Tumor, Soft Tissue Sarcoma
Interventions: Proton Therapy (Adaptive); Radiation
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Memphis, Tennessee

Search by objective public record fields.

BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Cannabis-Tobacco Co-Use Treatment Study

Comparison of Double Lumen Tube Placement Techniques

UM CRMC RecuR Score Pilot

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

Hepatitis C Diagnosis to Treatment Management

Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer

Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant

A Trial to Evaluate Medically Tailored Meals With Patients With Heart Failure

IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED

A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

Intradiscal Platelet Rich Plasma

SIMpill Medication Dispensing Device in the Treatment of HCV

Comparative Prevention-effectiveness Trial of DabirAIR Overlay System

Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma

Hepatitis C Screening Alerts

Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

Improving Postoperative Recovery: A Study of Multimodal Perineal Analgesia Protocol (MPAP) After Vaginal Surgery

Treatment for Psychological and Drug Abuse Problems

Cooperative Assessment of Late Effects for SCD Curative Therapies

RESPECT-PLUS: Services for Infants With Prenatal Opiate Exposure

Extending Long-term Outcomes Through an Adaptive Aftercare Intervention

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma